Short answer
RET V804M, also written p.Val804Met, is a specific RET variant that has been discussed in MEN2A and familial medullary thyroid cancer contexts and is commonly described in lower-risk or moderate-risk RET categories. Interpretation still depends on the lab's classification, whether the result is germline or tumor-only, the person's age and calcitonin context, and family history. Do not treat V804M like the highest-risk MEN2B codon 918 pattern.
How to frame the result
| Detail | Common next question | Why it matters |
|---|---|---|
| Germline V804M | Is the report pathogenic, likely pathogenic, or uncertain? | Management follows the lab classification and specialist review. |
| Moderate-risk language | What surveillance plan fits this family? | Moderate risk does not mean no risk or automatic surgery. |
| Tumor-only V804M | Was germline confirmation recommended? | Tumor findings and inherited risk are different questions. |
What to do next
- Confirm the exact notation on the report: c.2410G>A, p.Val804Met, V804M, or another codon 804 change.
- Check whether the sample was blood/saliva, tumor tissue, or circulating tumor DNA.
- Ask how the clinician wants to use calcitonin, thyroid ultrasound, adrenal screening, and family testing.
- Review whether relatives have medullary thyroid cancer, thyroidectomy, pheochromocytoma, hyperparathyroidism, or unknown thyroid cancer.
How to read results
| Result type | What it usually means | Next question |
|---|---|---|
| Pathogenic or likely pathogenic V804M | The variant may fit a MEN2A/FMTC style risk pattern. | What surveillance or family testing starts now? |
| V804M on tumor-only testing | May reflect a somatic cancer change rather than inherited risk. | Is germline confirmation recommended? |
| V804M with family history of MTC | The result may have more significance in that family context. | Should relatives be offered targeted testing? |
| VUS or uncertain 804 change | Not a confirmed family-risk result. | Will the lab reclassify it later? |
When family history changes the next step
Follow-up matters more when V804M is being used to decide whether a family has MEN2A, whether the result is moderate-risk rather than highest-risk, or whether relatives need targeted testing. Genetics counseling helps separate the codon label from the actual family plan.
When specialist review matters
Specialist review matters when a moderate-risk RET variant needs to be translated into a family-specific screening schedule.
How genetic testing is done
Genetic testing is usually done with blood or saliva, and the lab workflow depends on whether the question is a targeted variant, a panel, or confirmation after a clinical finding. Genetics counseling can help clarify whether the next step is a new test, family testing, or a different clinical workup.
Questions to ask
- What exact notation is on the report: c.2410G>A, p.Val804Met, V804M, or another codon 804 variant?
- Was the sample blood/saliva, tumor tissue, or circulating tumor DNA?
- Does the clinician recommend calcitonin, thyroid ultrasound, pheochromocytoma screening, or family testing?
- Do any relatives have medullary thyroid cancer, thyroidectomy, pheochromocytoma, or parathyroid disease?
- Does the result stay in a moderate-risk bucket, or does the family history change the plan?
FAQ
Why is RET V804M usually treated differently from RET codon 918?
V804M is usually discussed in a lower or moderate-risk MEN2 context, while codon 918 is one of the classic highest-risk MEN2B variants.
Does V804M automatically mean MEN2A?
Not automatically. The lab classification, whether the result is germline or tumor-only, and the family history all matter.
Why does moderate-risk language matter?
Moderate-risk language means the variant still matters, but the surveillance and timing may differ from the highest-risk RET patterns.
Can V804M be seen in families with medullary thyroid cancer?
Yes. V804M has been reported in MEN2A or familial medullary thyroid cancer settings, so family testing and specialist review still matter.
Should a tumor-only V804M finding be treated like an inherited result?
Usually not. Tumor-only RET findings can be somatic, so germline confirmation may be needed before family decisions are made.
Who should help interpret the report?
Genetics and endocrinology are usually the right team to translate the variant into a family-specific surveillance plan.